Wilhelm Michel is a Swiss entrepreneur and businessperson who founded 5 companies, among them: Ypsomed Holding AG, Disetronic Holding AG and Diabetes Center Berne Foundation and who has been at the head of 11 different companies. Presently, Dr. Michel occupies the position of Non-Executive Chairman of Ypsomed Holding AG (which he founded in 2003), Chairman-Supervisory Board of Fertility Biotech AG (which he founded in 2016), Chairman-Trustees Board at Diabetes Center Berne Foundation (which he founded in 2017), Chairman-Supervisory Board at Adval Tech Holding (Germany) GmbH and Chairman-Supervisory Board at Techpharma Management AG. Dr. Michel is also on the board of BV Holding AG (former Chairman) and Faes Bau AG.

In his past career Dr. Michel held the position of Chairman at Adval Tech Holding AG, Chief Executive Officer & General Manager for Novo Nordisk Pharma AG, Owner at Museum Franz Gertsch, Chairman & General Manager for Disetronic Holding AG (he founded the company in 1984), Chairman & Chief Executive Officer for Disetronic Medical Systems AG, Chairman of Finox AG (he founded the company in 2007) and Owner at Finox Beteiligungen AG.